Two Studies Shed Light on IBD Treatment After Anti-TNF Failu

Separate studies compared vedolizumab with tofacitinib in ulcerative colitis and to ustekinumab in Crohn's disease.

Related Keywords

New York , United States , Lenox Hill Hospital , Spain , France , French , Arun Swaminath , Vifor Pharma , Anthony Buisson , Universitario Marqu , Maria Jose Garcia , Amgen , Pfizer , Colitis Organisation , Boehringer Ingelheim , Clermont Auvergne University In Ferrand , European Crohn , Clermont Auvergne University , Hospital Universitario Marqu , Medscape Medical News , Crohns Disease , Medical Conferences , Ulcerative Colitis , Professional Societies , Anti Tnf , Anti Tumor Necrosis Factor , Biologic Therapy , Inflammatory Bowel Disease , Nflammatory Bowel Disease Ibd , Bd , Clinical Research , Clinical Trials , Linical Studies , Europe , European , Healthcare And Medical Technology , Ealth And Medical Tech , Ealth And Med Tech , Ealth And Medical Technology , Arthralgia , Ai ,